Post-approval studies (Phase 4)Study completedNCT00491244
What this trial is testing
Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C
Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 377